Clinicopathologic and Molecular Characterization of Anorectal Neuroendocrine Carcinomas Reveals Human Papillomavirus, p53, and c-Myc as Alternative Mechanisms of Carcinogenesis

Lokuhetty, 2018 Assarzadegan, 2021, What is new in the 2019 World Health Organization (WHO) classification of tumors of the digestive system: review of selected updates on neuroendocrine neoplasms, appendiceal tumors, and molecular testing, Arch Pathol Lab Med, 145, 664, 10.5858/arpa.2019-0665-RA Rindi, 2018, A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal, Mod Pathol, 31, 1770, 10.1038/s41379-018-0110-y Jesinghaus, 2017, Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas, Mod Pathol, 30, 610, 10.1038/modpathol.2016.220 La Rosa, 2012, Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: an update, Cancers (Basel), 4, 11, 10.3390/cancers4010011 de Mestier, 2017, Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms, Neuroendocrinology, 105, 412, 10.1159/000475527 Zhang, 2018, Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers, Nat Commun, 9, 4080, 10.1038/s41467-018-06177-2 Jiborn, 1998, Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment, Urology, 51, 585, 10.1016/S0090-4295(97)00684-5 Strosberg, 2010, The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas, Pancreas, 39, 799, 10.1097/MPA.0b013e3181ebb56f Benson, 2021, Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology, J Natl Compr Canc Netw, 19, 329, 10.6004/jnccn.2021.0012 Wistuba, 2001, Molecular genetics of small cell lung carcinoma, Semin Oncol, 28, 3, 10.1053/sonc.2001.25738 Chen, 2021, Poorly differentiated neuroendocrine carcinomas of the gastrointestinal tract: a single-institute study of 43 cases, Pathol Res Pract, 226, 10.1016/j.prp.2021.153614 Shamir, 2019, Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma, Mod Pathol, 32, 290, 10.1038/s41379-018-0131-6 Burd, 2003, Human papillomavirus and cervical cancer, Clin Microbiol Rev, 16, 1, 10.1128/CMR.16.1.1-17.2003 Yim, 2005, The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis, Cancer Res Treat, 37, 319, 10.4143/crt.2005.37.6.319 McBride, 2017, The role of integration in oncogenic progression of HPV-associated cancers, PLoS Pathog, 13, 10.1371/journal.ppat.1006211 Kim, 2007, HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation, Int J Cancer, 120, 1418, 10.1002/ijc.22464 Ferber, 2003, Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma, Oncogene, 22, 7233, 10.1038/sj.onc.1207006 Liao, 2022, A review and update on epithelial tumors of the anal canal, J Clin Transl Pathol, 2, 149 Ueberroth, 2021, Neuroendocrine carcinoma of the anus and rectum: patient characteristics and treatment options, Clin Colorectal Cancer, 20, e139, 10.1016/j.clcc.2020.12.001 Pessia, 2020, Squamous cell anal cancer: management and therapeutic options, Ann Med Surg (Lond), 55, 36, 10.1016/j.amsu.2020.04.016 Tomita, 2020, Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors, Bosn J Basic Med Sci, 20, 336 Kontogianni, 2005, CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact, J Clin Pathol, 58, 978, 10.1136/jcp.2004.023044 Goto, 1992, A novel human insulinoma-associated cDNA, IA-1, encodes a protein with “zinc-finger” DNA-binding motifs, J Biol Chem, 267, 15252, 10.1016/S0021-9258(18)42173-4 Beck, 2004, The role of Cdx genes in the mammalian gut, Gut, 53, 1394, 10.1136/gut.2003.038240 Erickson, 2004, Cdx2 as a marker for neuroendocrine tumors of unknown primary sites, Endocr Pathol, 15, 247, 10.1385/EP:15:3:247 Bellizzi, 2020, SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas, Histopathology, 76, 251, 10.1111/his.13943 Mills, 2006, p63: oncogene or tumor suppressor?, Curr Opin Genet Dev, 16, 38, 10.1016/j.gde.2005.12.001 Cimino-Mathews, 2012, Detection of human papillomavirus in small cell carcinomas of the anus and rectum, Am J Surg Pathol, 36, 1087, 10.1097/PAS.0b013e3182549b6d Hwang, 2020, Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer, J Pathol Transl Med, 54, 378, 10.4132/jptm.2020.06.01 Zhu, 2021, Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status, Mod Pathol, 34, 1017, 10.1038/s41379-020-00729-y Herfs, 2018, A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine, Br J Cancer, 118, 1302, 10.1038/s41416-018-0049-2 Kalkat, 2017, MYC deregulation in primary human cancers, Genes (Basel), 8, 151, 10.3390/genes8060151 Ho, 2005, p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest, Mol Cell Biol, 25, 7423, 10.1128/MCB.25.17.7423-7431.2005 Sachdeva, 2009, p53 represses c-Myc through induction of the tumor suppressor miR-145, Proc Natl Acad Sci U S A, 106, 3207, 10.1073/pnas.0808042106 Ulz, 2016, Co-occurrence of MYC amplification and TP53 mutations in human cancer, Nat Genet, 48, 104, 10.1038/ng.3468